Furthermore, the overexpression of ITGA2 could significantly inhibit the mRNA level of SMAD2 in pancreatic cancer cells, but not those of the SMAD3 or SMAD4 (Fig. 4e-g). This evidence concerns the gene SMAD3 and familial pancreatic carcinoma.